USA - New York Stock Exchange - NYSE:HQL - US87911K1007
The current stock price of HQL is 16.99 USD. In the past month the price decreased by -1.43%. In the past year, price increased by 27.63%.
abrdn Life Sciences Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies. The Fund invests primarily in securities of public and private companies. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
The current stock price of HQL is 16.99 USD. The price decreased by -1.39% in the last trading session.
HQL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ChartMill assigns a technical rating of 9 / 10 to HQL. When comparing the yearly performance of all stocks, HQL is one of the better performing stocks in the market, outperforming 84.84% of all stocks.